Oct 30, 2025 7:00am EDT iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance
Oct 23, 2025 7:00am EDT iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference